[Retracted] HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer

Figure 11

KEGG enrichment analysis of HHLA2 in various cancers. KEGG pathways associated with HHLA2 in ACC, BRCA, COAD, HNSC, LAML, KIRC, PAAD, PRAD, and UCEC.